secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRO DEX INC (PDEX)
CIK:        0000788920
Form:       8-K
Filed at:   2021-08-26T23:59:59+00:00
Accession:  0001553350-21-000747
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pro-Dex Q4 revenue falls 15% YoY; full-year sales up 9%
-------------------------------------------------------

- Q4 net sales $9.4M (-15% YoY); net income $0.9M ($0.22 diluted EPS) vs $2.5M ($0.64) prior year.
- FY2021 net sales $38.0M (+9% YoY); net income $4.5M ($1.13 EPS) down from $6.1M ($1.50).
- Operating expenses up 49% to $9.1M, driven by increased R&D ($2.1M) and stock compensation ($615K).
- R&D pipeline: ENT Shaver launches Q4 2021 (est. $1M annual rev); Vital Ventilator targets Q1 2022 ($1.5M est.).
- COVID-19 caused under-absorbed manufacturing costs; supply chain delays ongoing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/788920/000155335021000747/0001553350-21-000747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/788920/000155335021000747/pdex_8k.htm
  HTML page:      https://secwatch.observer/filing/0001553350-21-000747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer